Что необходимо знать кардиологу об искусственном кровообращении?
Аннотация
В статье отражены некоторые этапы развития экстракорпорального кровообращения, начиная с момента первого упоминания о нем и заканчивая сегодняшним днем. Внимание сосредоточено на основных принципах проведения искусственного кровообращения (ИК), критериях адекватности перфузии и ее контролируемых параметрах. Более подробно освещены причины развития постперфузионного синдрома, связанного с системным воспалительно-коагуляционным ответом организма при кардиохирургических вмешательствах с временным замещением функций сердца и легких аппаратом ИК.Литература
1. Абрамян М. А. Модифицированная ультрафиль- трация в ближайшем постперфузионном пери- оде у новорожденных и грудных детей: Авто- реф. дис. … канд. мед. наук. – М., 2000.2. Бокерия Л. А., Гудкова Р. Г. Сердечно-сосудистая хирургия – 2005. Болезни и врожденные анома- лии системы кровообращения. – М.: НЦССХ им. А. Н. Бакулева РАМН, 2006. – 114 с.
3. Борисов В. И. Пособие, регламентирующее проведение искусственного кровообращения. – М.: Изд-во НЦССХ им. А. Н. Бакулева РАМН, 2003. – 16 с.
4. Борисов В. И. Состояние микроциркуляторного сосудистого русла в условиях искусственного кровообращения по данным бульбарной мик- роангиоскопии: Дис. … канд. мед. наук. – М., 1977. – 133 с.
5. Брюхоненко С. С. Искусственное кровообраще- ние. – М.: Медицина. Наука, 1964. – С. 6–12.
6. Галетти П. М., Бричер Г. А. Основы и техника экстракорпорального кровообращения. – М.: Медицина, 1966. – 295 с.
7. Дементьева И. И., Чарная М. А., Морозов Ю. А. Применение трасилола в кардиохирургии: Ме- тодические рекомендации. – М., 2003. – 31 с.
8. Загвоздкин В. И. К вопросу о взаимосвязи ге- модинамики, транспорта и потребления кис- лорода во время искусственного кровообраще- ния: Автореф. дис. … канд. мед. наук. – М., 1973. – 21 с.
9. Зильбер А. П. Клинико-физиологические осно- вы кровопотери и гемотрансфузии // Сборник докладов Всероссийского научно-практическо- го симпозиума с международным участием ≪Бескровная хирургия – итоги и перспективы≫. –М., 2002. –С. 22–3.
10. Ильин В. Н. Комбинированный метод глубокой гипотермии для коррекции пороков сердца у детей раннего возраста: Дис. … канд. мед. наук. – М., 1978.
11. Кламмер М. Е. Глубокая гипотермия при опера- циях на открытом сердце: Автореф. дис. … канд. мед. наук. – М., 1965. – 21 с.
12. Кобахидзе Э. А. Некоторые вопросы методики и клинического применения искусственного кро- вообращения без донорской крови: Дис. … канд. мед. наук. – 1975. – 130 с.
13. Колударов В. В. Искусственное кровообращение в условиях гипотермии у детей до трех лет с ВПС: Дис. … канд. мед. наук. – М., 1987.
14. Логинова Л. И., Соболева Е. Р., Симанов В. А. Ла- боратория искусственного кровообращения // История Научного центра сердечно-сосудистой хирургии им. А. Н. Бакулева РАМН / Под ред. Л. А. Бокерия, А. А. Спиридонова. – М.: НЦССХ им. А. Н. Бакулева РАМН, 1998. – С. 140–142.
15. Локшин Л. С., Лурье Г. О., Дементьева И. И. Ис- кусственное и вспомогательное кровообраще- ние в сердечно-сосудистой хирургии. – М., 1998. – 212 с.
16. Меньшугин И. Н. Искусственное кровообраще- ние у детей в условиях ганглионарной блокады и пульсирующего потока: Руководство для вра- чей. – СПб.: Специальная литература, 1998. – 127 с.
17. Осипов В. П. Основы искусственного кровооб- ращения. – М., 1976. – 320 с.
18. Шипулин В. М., Мерунко А. А. Ультрафильтрация крови в детской кардиохирургии. – Томск: STT, 2002. – 136 с.
19. Allen B. S., Illbawi M. N. Hypoxia, reoxygenation and the role of systemic leukodepletion in pediatric heart surgery // Perfusion. – 2001. – Vol. 16 (Suppl.). – P. 19–29.__
20. Anand K. J., Hensen D. D., Hickey P. R. Hormonal metabolic stress responses in neonates undergoing cardiac surgery // Anesthesiology. – 1990. – Vol. 73. – P. 661–670.
21. Ashraf S., Tian Y., Zacharrias S. et al. Effects of cardiopulmonary bypass on neonatal and pediatric inflammatory profiles // Eur. J. Cardiothorac. Surg. – 1997. – Vol. 12. – P. 862–868.
22. Asimakopoulos G. The inflammatory response to СРВ: the role of leukocyte filtration // Perfusion. – 2002. – Vol. 17. – P. 7–10.
23. Asimakopoulos G., Thompson R., Nourshargh S. et al. An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation // J. Thorac. Cardiovasc. Surg. – 2000. – Vol. 120. – P. 361–369.
24. Bando K., Turrentine M. W., Palaniswamy V. et al. Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease // Ann. Thorac. Surg. – 1998. – Vol. 66. – P. 821–828.
25. Bando K., Vijay P., Turrentine M. W. et al. Dilutional and modified ultrafiltration reduces pulmonary hypertension after operations for congenital heart disease: a prospective randomized study // J. Thorac. Cardiovasc. Surg. – 1998. – Vol. 115. – P. 361–369.
26. Beattie H. W., Evans G., Garnet E. S. et al. Albumin and water fluxes during cardiopulmonary bypass // J. Cardiovasc. Surg. – 1974. – Vol. 67. – P. 926–931.
27. Bengi E. C., Gormus N., Okesli S. et al. Methylprednisolone prevents inflammatory reaction occurring during cardiopulmonary bypass: effects on TNF-α, IL-6, IL-8, IL-10 // Perfusion. – 2004. – Vol. 19. – P. 185–191.
28. Boettcher W., Merkle F., Koster A. et al. Safe minimization of cardiopulmonary bypass circuit volume for complex cardiac surgery in a 3.7 kg neonate // Perfusion. – 2003. – Vol. 18. – P. 377–379.
29. Borhetti V., Piccin C., Luciani G. B. et al. Postperfusionssyndrom // Extrakorporale Zirkulation in Theorie und Praxis / Ed. R. J. Tschaut. – Lengerich – Berlin – Dьsseldorf – Leipzig – Riga – Scottdale (USA) – Wien – Zagreb: Pabst, 1999. – P. 467–488.
30. Bцttger P. F. Hypotermie // Extrakorporale Zirkulation in Theorie und Praxis / Ed. R. J. Tschaut. – Lengerich – Berlin – Dьsseldorf – Leipzig – Riga – Scottdale (USA) – Wien – Zagreb: Pabst, 1999. – P. 238–248.
31. Bove E. L., Lloyd T. R. Staged reconstruction for hypoplastic left heart syndrome // Ann. Surg. – 1996. – Vol. 224. – P. 387–395.
32. Brix-Christensen V. The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children // Acta Anesthesiol. Scand. – 2001. – Vol. 45. – P. 671–679.
33. Bronicki R. A., Backer C. L., Baden H. P. et al. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children // Ann. Thorac. Surg. – 2000. – Vol. 69. – P. 1490–1495.
34. Butler J., Pathi V. L., Paton R. D. et al. Acute-phase responses to cardiopulmonary bypass in children weighing less than 10 kilograms // Ann. Thorac. Surg. – 1996. – Vol. 62. – P. 538–542.
35. Chew M., Branslund I., Brix-Christensen V. et al. Tissue injury and Inflammatory Response to pediatric cardiopulmonary Bypass // Anesthesiology. – 2001. – Vol. 94. – P. 745–753.
36. Chew M., Brix-Christensen V., Ravn H. B. et al. Effect of modified ultrafiltration on the inflammatory response in pediatric open-heart surgery: a prospective, randomized study // Perfusion. – 2002. – Vol. 17. – P. 327–333.
37. Chira M., Butyka R., Molnar A. Conventional and modified ultrafiltration in pediatric patients – improved outcome // Proceedings of the 10th European Congress on Extra-Corporeal Circulation Technology. Madeira, Portugal / Eds T. A. Buckingham, J. Steenbrink, M. J. Wijers-Hille, D. S. de Jong. – Bratislava, 2003. – P. 263–270.
38. Cremer J. M., Redl H. et al. Systemic inflammatory response syndrome after cardiac operations // Ann. Thorac. Surg. – 1996. – Vol. 61. – P. 1714.
39. De Somer F., Francois K., van Oeveren W. et al. Phosphorylcholine coating of extracorporeal protection against blood activation by the material surface // Eur. J. Cardiothoracic. Surg. – 2000. – Vol. 18. – P. 602–606.
40. De Somer F., van Belleghem Y., Caes F. et al. Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass // Perfusion. – 2002. – Vol. 17. – P. 39–44.
41. Dexter F., Kern F. H., Hindman B. J., Greeley W. J. The brain uses mostly dissolved oxygen during profoundly hypothermic cardiopulmonary bypass // Ann. Thorac. Surg. – 1997. – Vol. 63. – P. 1725–1729.
42. Du Plessis A. J., Jonas R. A., Wypij D. et al. Perioperative effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants // J. Thorac. Cardiovasc. Surg. – 1997. – Vol. 114. – P. 991–1001.
43. Duval E. L. I. M., Kavelaars A., Veenhuisen L. et al. Pro- and anti-inflammatory cytokine patterns during and after cardiac surgery in young children // Eur. J. Pediatr. – 1999. – Vol. 158. – P. 387–393.
44. Englberger L., Kipfer В., Berdat P. A. et al. Aprotinin in Coronary Operation With cardiopulmonary bypass: Does ≪Low-Dose≫ Aprotinin Inhibit the Inflammatory Response? // Ann. Thorac. Surg. – 2002. – Vol. 73. – P. 1897–1904.
45. Fang W. C., Helm R. E., Krieger К. H. et al. Impact of minimum haematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery // Circulation. – 1997. – Vol. 96. – P. 194II–199II.
46. Finn A., Naik S., Klein N. et al. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass // J. Thorac. Cardiovasc. Surg. – 1993. – Vol. 105. – P. 234–241.
47. Fitzgerald D. J., Cecere G. Hemofiltration and inflomantory mediators // Perfusion. – 2002. – Vol. 17. – P. 23–28.
48. Forest R. J., Groom R. С., Quinn R. et al. Repair of hypoplastic left heart syndrome of a 4.25 kg Jehovah’s witness // Perfusion. – 2002. – Vol. 17. – P. 221–225.
49. Glasmacher B., Sellin L. Werkstoffkunde // Extrakorporale Zirkulation in Theorie und Praxis / Ed. R. J. Tschaut. – Lengerich – Berlin – Dьsseldorf – Leipzig – Riga – Scottdale (USA) – Wien – Zagreb: Pabst, 1999. – P. 251–263.
50. Gott J. P., Cooper W. A., Schmidt F. E. et al. Modibyng risk for extracorporeal circulation: trial of four anti-inflammatory strategies // Ann. Thorac. Surg. – 1998. – Vol. 66. – P. 747–753.
51. Greeley W. J., Kern F. H., Ungerleider R. M. et al. The effect of hypothermic cardiopulmonary bypass and total circulatory arrest on cerebral metabolism in neonates, infants, and children // Thorac. Cardiovasc. Surg. – 1991. – Vol. 101. – P. 783–794.
52. Groom R. C., Froebe S., Martin J. et al. Update on Pediatric Perfusion Practice in North America: 2005 Survey // JECT. – 2005. – Vol. 37. – P. 343–350.
53. Groom R. G. High or low haematocrits during cardiopulmonary bypass for patients undergoing coronary artery bypass graft surgery? An evidence-based approach to the question // Perfusion. – 2001. – Vol. 16. – P. 339–343.
54. Grunenfelder J., Zund G., Schoeberlein A. et al. Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass without clinical relevance in adults // Eur. J. Cardiothorac. Surg. – 2000. – Vol. 17. – P. 77–83.
55. Gunaidin S. Clinical significance of coated extracorporeal circuits: a review of novel technologies // Perfusion. – 2004. – Vol. 6. – P. 33–41.
56. Habib K. M., Zacharias A., Schwann T. A. et al. Adverse effects of low haematocrit during cardiopulmonary bypass in the adult: should current practice be changed? // J. Thorac. Cardiovasc. Surg. – 2003. – Vol. 125. – P. 1438–1450.
57. Harig F., Feyrer R., Mahmound F. O. et al. Reducing the post-pump syndrome by using heparin-cjated circuits, steroids, or aprotinin // J. Thorac. Cardiovasc. Surg. – 1999. – Vol. 47. – P. 111–118.
58. Harker L. A., Malpass T. W., Branson H. et al. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: a equired transient platetet disfunction associated with selective alpha-granule release // Blood. – 1980. – Vol. 56. – P. 824–834.
59. Hill G. E., Alonso A., Spurzem J. R. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass –induced inflammation in humans // Ibid. – 1995. – Vol. 110. – P. 1658–1662.
60. Hill G. E., Diego R. P., Stammers A. H. et al. Aprotinin enchanges the endogenous release of interleukin-1o after cardiac operations // Ann. Thorac. Surg. – 1998. – Vol. 65. – P. 66–69.
61. Hцvels-Gьrich H. H., Jaime F. et al. Production of proinflamantory cytokines and myocardial dysfunction after arterial switch operation in neonates with transposition of the great arteries // J. Thorac. Cardiovasc. Surg. – 2002. – Vol. 124. – P. 811–820.
62. Hunt B. J., Parzatt R. N., Segal H. С. et al. Activation of coagulation and fibrinolysis during, cardiothoracic operations // Ann. Thorac. Surg. – 1998. – Vol. 65. – P. 712–718.
63. Huyzen R. J., van Oeveeren W., Wei F. et al. In vivo effect of hemodilution or ACT and high-dose thrombin time during cardiopulmonary bypass // Ann. Thorac. Surg. – 1996. – Vol. 83. – P. 459–465.
64. Janvier G., Baquey C., Roth C. et al. Extracorporeal circulation, hemocompatibility, and biomaterials // Ann. Thorac. Surg. – 1996. – Vol. 62. – P. 1926–1934.
65. Jenkins E. (Ed.). Protocols and guidelines for pediatric perfusion. – Copyright 1998. The Regents of the University of Michigan.
66. Journois D., Israel-Biet D., Pouard P. et al. Highvolume, zero-balanded hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children // Anesthesiology. – 1996. – Vol. 85. – P. 965–976.
67. Journois D., Pouard P., Greeley W. J. et al. Hemotiltration during cardiopulmonary bypass in pediatric cardiac surgery: Effects on hemostasis, cytokines and complement components // Anesthesiology. – 1994. – Vol. 81. – P. 1181–1189.
68. Kawata H., Fackler J. C., Aoki M. et al. Recovery of cerebral blood flow and energy state in piglets after hypothermic circulatory arrest versus recovery after low-flow bypass // Thorac. Cardiovasc. Surg. – 1993. – Vol. 106. – P. 671–685.
69. Kimura T., Muraoka R., Chiba Y. et al. Effect of intermittent deep hypothermic circulatory arrest on brain metabolism // J. Thorac. Cardiovasc. Surg. – 1994. – Vol. 108. – P. 658–663.
70. Kirklin J. K. Prospects for understanding and elimination the deleterious effects of cardiopulmonary bypass // Ann. Thorac. Surg. – 1991. – Vol. 51. – P. 529–534.
71. Kirshbom P. M., Skaryak L. A., DiBeraardo L. R. et al. Effects of aortopulmonary collaterals on cerebral cooling and cerebral metabolic recovery after circulatory arrest // Circulation. – 1995. – Vol. 92. – P. 11490–11494.
72. Lauterbach G. Geschichte der Kardiotechnik. Geschichtlicher Rьblik – Entwicklung der Kardiotechnik // Extrakorporale Zirkulation in Theorie und Praxis / Ed. R. J. Tschaut. – Lengerich – Berlin – Dьsseldorf – Leipzig – Riga – Scottdale (USA) – Wien – Zagreb: Pabst, 1999. – S. 19–25.
73. Lerzo F., Borini G., Cervo A. M. Ultrafiltration strategies in small babies: what is the best approach? // Proceedings of the 10th European Congress on Extra-Corporeal Circulation Technology. Madeira, Portugal / Eds T. A. Buckingham, J. Steenbrink, M. J. Wijers-Hille, D. S. de Jong. – Bratislava, 2003. – P. 255–262.
74. Marie C., Fitting C., Muret J. Interleurin-8 production in whole assays: Is interleukin-10 responsible for the down regulation observed in sepsis? // Cytocine. – 2000. – Vol. 12. – P. 55–61; 220.
75. Massoudy P., Zahler S., Freyholdt T. et al. Sodium nitroprusside in patient with compromised left ventricular function undergoing coronary bypass: reduction of cardiac proinflammatiry substances // J. Thorac. Cardiovasc. Surg. – 2000. –Vol. 119. –P. 566–574.
76. Mayumi H., Zhang Q. W., Nakashima A. et al. Synergetic immunosupression caused by high-dose Ann. Thorac. Surg. – 1997. – Vol. 63. – P. 129–137.
77. Merkle F., Boettcher W., Schulz F. et al. Perfusion technique for nonhaemic cardiopulmonary bypass prime in neonates and infants under 6 kg body weight // Perfusion. – 2004. – Vol. 19. – P. 229–237. 78. Mitchel B. A. A search for the lowest infant prime volume // E-Jornal of Perfusion Technol. – 2002.
79. Moosdorf R., Vogt S. et al. Chirurgische Schnittfьrung, Zugangswege und Kanьlierungstechnicken zum anschluβ der Herz-Lungen- Maschine // Extrakorporale Zirkulation in Theorie und Praxis / Ed. R. J. Tschaut. – Lengerich – Berlin – Dьsseldorf – Leipzig – Riga – Scottdale (USA) – Wien – Zagreb: Pabst, 1999.
80. Myers G. J., Johnstone D. R., Swyer W. J. et al. Evaluation of mimesis phosphorylcholine (PC)- coated oxygenators during cardiopulmonary bypass in adults // JECT. – 2003. – Vol. 35. – P. 6–12.
81. Nollert G., Nagashima M., Bucerius J. et al. Oxygenation strategy and neurologic damage after deep hypothermic circulatory arrest. I. Gaseous microemboli // J. Thorac. Cardiovasc. Surg. – 1999. – Vol. 117. – P. 1166–1171.
82. Norwood W. I., Ingwall I. S., Norwood C. R. Developmental changes in creatine kinase metabolism in rat brain // Amer. J. Physiol. – 1983. – Vol. 244. – P. 205–254.
83. Oyama J., Shimokawa H., Motii H. et al. Role of nitric oxid and peroxynitrite in the cytocine-induced sustained myocardial dysfunction in dogs in vivo // J. Clin. Invest. – 1998. – Vol. 101. – P. 2207–2214.
84. Pappalardo F., Della Valle P., Crescenzi G. et al. Phosphorylcholine coating may limit trombin formation during high-risk cardiac surgery: a randomized controlled trial // Ann. Thorac. Surg. – 2006. – Vol. 81. – P. 886–891.
85. Paschke K. Perfusion bei Aortenaneurismen // Extrakorporale zirkulation in theorie und praxis / Ed. R. J. Tschaut. – Lengerich – Berlin – Dьsseldorf – Leipzig – Riga – Scottdale (USA) – Wien – Zagreb: Pabst, 1999. – S. 762–772.
86. Pavan G., De Cicco G., Del Bono R. Effects of phosphorylcholine coating on exstracorporeal circulation management and postoperative outcome // Procedings of the 10th European Congress on Extra-Corporeal Circulation Technology. Madeira, Portugal / Eds T. A. Buckingham, J. Steenbrink, M. J. Wijers-Hille, D. S. de Jong. – Bratislava, 2003. – P. 191–201.
87. Pearl J. M., Manning P. B., McNamara J. L. et al. Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, endothelin-1 in infants undergoing cardiopulmonary bypass // Ann. Thorac. Surg. – 1999. – Vol. 68. – P. 1369–1375.
88. Rinder С. S., Bohnert J., Rinder H. M. et al. Platelet activation and aggregation during cardiopulmonary bypass // Anesthesiology. – 1991. – Vol. 75. – P. 388–393.
89. Rinder С. S., Bonac J. L., Rinder H. М. et al. Cardiopulmonary bypass induced leukocyte-platelet adgesion // Blood. – 1992. – Vol. 79. – P. 1201–1205.
90. Ruck K., Wendt G. Filtertechnik in der exstrakorporalen Zirkulation // Extrakorporale Zirkulation in Theorie und Praxis / Ed. R. J. Tschaut. – Lengerich – Berlin – Dьsseldorf – Leipzig – Riga – Scottdale (USA) – Wien – Zagreb: Pabst, 1999. – S. 331–341.
91. Scallan M. J. H. Cerebral injury during pediatric heart surgery: perfusion issues // Perfusion. – 2004. – Vol. 19. – P. 221–228.
92. Schmartz D., Tabardel Y., Preiser J. et al. Does aprotinin influence the inflammatory response to cardiopulmonary bypass in patients // J. Thorac. Cardiovasc. Surg. – 2003. – Vol. 125. – P. 184–190.
93. Schmitz C. Kinderherzhirurgie // Extrakorporale Zirkulation in theorie und praxis / Ed. R. J. Tschaut. – Lengerich – Berlin – Dьsseldorf – Leipzig – Riga – Scottdale (USA) – Wien – Zagreb: Pabst, 1999. – S. 607 – 632.
94. Seghaye M., Duchateau J., Bruniaux J. et al. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations // Thorac. Cardiovasc. Surg. – 1996. – Vol. 111. – P. 545–553.
95. Stein J. I., Gombotz H., Rigler B. et al. Open heart surgery in children of Jehovah’s Witnesses: extreme hemodilution on cardiopulmonary bypass // Pediatr. Cardiol. – 1991. – Vol. 12. – P. 170–174.
96. Swain J. A., McDonald T. J. Jr, Griffith P. K. et al. Low-flow hypothermic cardiopulmonary bypass protects the brain // Thorac. Cardiovasc. Surg. – 1991. – Vol. 102. – P. 76–83.
97. Tarnok A., Hambsch J., Emmrich F. et al. Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass // Pediatr. Cardiol. – 1999. – Vol. 20. – P. 113–125.
98. Tassani P., Barankay M., Haas F. et al. Cardiac surgery with deep hypothermic circulatory arrest produces less systemic inflammatory response than low-flow cardiopulmonary bypass in newborns // J. Thorac. Cardiovasc. Surg. – 2002. – Vol. 123. – P. 648–654.
99. Tschaut R. J., Latz S. Exstrakorporale zirkulation bei sдuglingen und kleinkindern // Extrakorporale zirkulation in theorie und praxis / Ed. R. J. Tschaut. – Lengerich – Berlin – Dьsseldorf – Leipzig – Riga – Scottdale (USA) – Wien – Zagreb: Pabst, 1999. – S. 633–647.
100.Vannucci R., Towfighi J., Heitjan D., Brucklacher R. Carbon dioxide protects the perinatal brain from hypoxic-ischemic damage: an experimental study in the immature rat // Pediatrics. – 1995. – Vol. 95. – P. 868–874 (Abstract).
101.Vocelka G. Minimizing the cardiopulmonary bypass circuit: a perfusionists perspective of the benefits and risks associated with the benefits and risks associated with the mini-circuit // Proceedings of the 10th European Congress on Extra-Corporeal Circulation Technology. Madeira, Portugal / Eds T. A. Buckingham, J. Steenbrink, M. J. Wijers-Hille, D. S. de Jong. – Bratislava, 2003. – P. 103–108.
102.Vцgel M., Liebig F. Der Einsatz in der leikozytendepletierender Filter in der Herz-Thorax-Chirurgie // Kardiotechnik. – 1994. – Bd. 3. – S. 22–25.
103.Wahba A., Rothe G., Lodes H. et al. Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass // Thromb. Res. – 2000. – Vol. 97. – P. 379–386.
104.Wang M., Chiu I., Hsu C., Wang C. et al. Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations // Ann. Thorac. Surg. – 1996. – Vol. 61. – P. 651–656.
105.Wang W., Huand H. M., Zhu D. M. et al. Modified ultrafiltration in pediatric cardiopulmonary bypass // Perfusion. – 1998. – Vol. 13. – P. 304–310.
106.Weerasinghe A., Taylor К. M. The platelet in cardiopulmonary bypass // Ann. Thorac. Surg. – 1998. – Vol. 66. – P. 2145–2152.
107.Wegner R. K., Lukasiewiez H., Mikuta B. S. et al. Loss of platetet fibrinogen receptors during cardiopulmonary bypass // J. Cardiovasc. Surg. – 1989. – Vol. 97. – P. 301.
108.Weitkemper H. H., Trotizsch D. et al. Priming von Extrakorporalen Kreisaufssystemen // Extrakorporale Zirkulation in Theorie und Praxis / Ed. R. J. Tschaut. – Lengerich – Berlin – Dьsseldorf – Leipzig – Riga – Scottdale (USA) – Wien – Zagreb: Pabst, 1999. – S. 342–347.
109.Wendel H. P. Heparinbeschichtete Systeme // Extrakorporale zirkulation in theorie und praxis / Ed. R. J. Tschaut. – Lengerich – Berlin – Dьsseldorf – Leipzig – Riga – Scottdale (USA) – Wien – Zagreb: Pabst, 1999. – S. 675–692.
110.Weyrich A. S., Ma X. Y., Lefer D. J. et al. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury // J. Clin Invest. – 1993. – Vol. 91. – P. 2620–2629.
111. Whitaker D. C., Stygall J., Newman S. P. Neuroprotection during cardiac surgery: strategies to reduce cognitive decline // Perfusion. – 2002. – Vol. 17. – P. 69–75.
112.Winn R. K., Liggitt D., Vedder N. B. et al. Anti-Pselectin monoclonal antibody attenuates reperfusion injury to the rabbit ear // J. Clin. Invest. – 1993. – Vol. 92. – P. 2042–2047.
113.Worrall N. K., Chang K., Lejeunne W. S. et al. TNF-α causes reversible in vivo systemic vascular barritr disfunction via NO-dependent and -independent mechanisms // Amer. J. Physiol. – 1997. – Vol. 273. – P. 2565–2574.
114. Wright G. Blutpumpen mit pulsatilem und nichpulsatilem (kontinuerlichem) Blutstrom fpцд-.fьr den kardiopulmonalen Bypass // Extrakorporale zirkulation in theorie und praxis / Ed. R. J. Tschaut. – Lengerich – Berlin – Dьsseldorf – Leipzig – Riga – Scottdale (USA) – Wien – Zagreb: Pabst, 1999. – S. 288–304.
115. Zahler S., Massoudy P., Hard C. et al. Acute cardiac inflammatory response to postischemic reperfusion during cardiopulmonary bypass // Cardiovasc. Res. – 1999. – Vol. 41. – P. 722–730.
